comparemela.com
Latest Breaking News On - Inflammation immunology discovery biology - Page 1 : comparemela.com
Agomab Therapeutics NV: Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114 Million
Extension led by Pfizer with participation from new investors Walleye Capital and Asabys Partners as well as existing investors Funding will support next stage of clinical and corporate development
Kostenloser-wertpapierhandel
Laura-mittmann
Tim-knotnerus
Thomas-wynn
Michael-vincent
Pfizer
Redmile-group
Trophic-communications
Pfizer-breakthrough-growth-initiative
Walleye-capital
Asabys-partners
Vice-president
vimarsana © 2020. All Rights Reserved.